NeutriSci International Inc.
NRXCF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.7% | -3.4% | -94% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 62.1% | 77.5% | 65.2% | -63.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,236.2% | -4,329.9% | -3,380.1% | -407.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,563.5% | -4,620.1% | -3,213% | -425.5% |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | 37.5% | -33.3% | 50% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |